FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/08/073095 [Registered on: 29/08/2024] Trial Registered Prospectively
Last Modified On: 15/08/2024
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug
Ayurveda 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Evaluate The Effect Of Dwitiya Baladi Yapana Basti With Trayodashang Guggulu Over Eranda Muladi Yapana Basti With Trayodashang Guggulu In Patients Having Katigraha (Lumbar Spondylosis) 
Scientific Title of Study   A comparative clinical study to evaluate the efficacy of Dwitiya Baladi Yapana Basti with Trayodashang Guggulu over Eranda Muladi Yapana Basti with Trayodashang Guggulu in the management of Katigraha (Lumbar spondylosis) 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sakshi Rajendra Thorat 
Designation  MD Scholar Department Of Kayachikitsa 
Affiliation  All India Institute Of Ayurveda  
Address  618(Seminar Hall) Department Of Kayachikitsa All India Institute Of Ayurveda Gautampuri Sarita Vihar New Delhi South Delhi 110076 India

South
DELHI
110076
India 
Phone  9075306167  
Fax    
Email  sakshithorat321@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Amrish Dedge 
Designation  Assistant Professor 
Affiliation  All India Institute Of Ayurveda 
Address  6th Floor Department Of Kayachikitsa All India Institute Of Ayurveda Gautampuri Sarita Vihar New Delhi South Delhi 110076 India

South
DELHI
110076
India 
Phone  9025638650  
Fax    
Email  dramrishaiia@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Amrish Dedge 
Designation  Assistant Professor 
Affiliation  All India Institute Of Ayurveda 
Address  6th Floor Department Of Kayachikitsa All India Institute Of Ayurveda Gautampuri Sarita Vihar New Delhi South Delhi 110076 India

South
DELHI
110076
India 
Phone  9025638650  
Fax    
Email  dramrishaiia@gmail.com  
 
Source of Monetary or Material Support  
All India Institute Of Ayurveda 
 
Primary Sponsor  
Name  All India Institute Of Ayurveda 
Address  Gautampuri Sarita Vihar New Delhi 110076 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sakshi Thorat  All India Institute Of Ayurveda   Gautampuri Sarita Vihar New Delhi 110076 South Delhi OPD Number 3 And 5 And IPD
South
DELHI 
9075306167

sakshithorat321@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
AIIA Institutional Ethics Committee  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:M478||Other spondylosis. Ayurveda Condition: TRIKAGRAHAH (KEVALAVATA),  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmProcedure-bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म (Procedure Reference: charak siddhi sthan adhyay 12 shloka 16, Procedure details: 1)Sarvang Abhyang -Dhanvantar taila(For 8 Days) 2)Sarvang Bashpa Sweda -Dashmool Kwatha(For 8 Days) 3)Anuvasan Basti -Dhanvantar Tail 60 ml(For 5 Days) 4)Niruha Basti-Dwitiya Baladi Yapana Basti 660 ml(For 3 Days))
(1) Medicine Name: Trayodashang Guggulu, Reference: Bhaishajya Ratnavali Vatvyadhi Adhikar , Route: Oral, Dosage Form: Guggulu, Dose: 500(mg), Frequency: bd, Duration: 38 Days
2Comparator ArmProcedure-bastikarma/vastikarma, बस्तिकर्म/वस्तिकर्म (Procedure Reference: Charak Siddhi Sthan Adhyay 12 Shloka 16 (2), Procedure details: 1)Sarvang Abhyang -Dhanvantar taila(For 8 Days) 2)Sarvang Bashpa Sweda -Dashmool Kwatha(For 8 Days) 3)Anuvasan Basti -Dhanvantar Tail 60 ml(For 5 Days) 4)Niruha Basti-Eranda Muladi Yapana Basti 660 ml(For 3 Days))
(1) Medicine Name: Trayodashang Guggulu, Reference: Bhaishajya Ratnavali Vatvyadhi Adhikar, Route: Oral, Dosage Form: Guggulu, Dose: 500(mg), Frequency: bd, Duration: 38 Days
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1)Patients Of Any Gender Of Age Between 21-50 Years
2)Patients Having Classical Clinical Signs And Symptoms Of Katigraha (Lumbar Spondylosis)With Shool Stambh Gaurav
3)ODI Scale Scoring Between 5-24 That Is Mild To Moderate Cases
4)Abendeen LBP Scale More Than 40
5)Controlled Diabetes Mellitus Hypothyroidism Hypertension 
 
ExclusionCriteria 
Details  1)Patients Having Any Other Spinal Morbidity Like Spinal Tumor Any Other Deformities Of Lumbar Spine
2) Recent Lumbar Surgery Less Than 3 Years Or Implanted Instruments Or Prostheses
3)Chronic Inflammatory Metabolic Or Infective Pathogies That Is Ankylosing Spondylitis Rheumatoid Arthritis Psoriatic Arthritis Gouty Arthritis Potts Spine Malignancy And Or Metastasis In Bones
4)Patients Using NSAIDs And Or Corticosteroids On Regular Basis
5)Anorectal Conditions Like Haemorrhoids Anorectal Fistulae Anal Fissure Anal Mass Etc Those May Interfere With Basti Chikitsa
6) Pregnant Or Lactating Women
7)Any Other Systemic Illnesses Like IHD Epilepsy COPD Etc
8)Katigraha Due To Other Causes Like Malignant Disease Of The Pelvis  
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Other 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
1)An improvement of about 30% in clinical symptoms of Katigraha in selected patients
2)An improvement of about 30% in range of motion of lower back in patients with Katigraha
3)An improvement of about 30% in quality of life in patients with Katigraha
4)Validation of the safety of ayurveda interventions proposed in Katigraha by assessing ADRs AEs if any
 
Day 0
Day 8
Day 38
 
 
Secondary Outcome  
Outcome  TimePoints 
1)An improvement of about 30% in clinical symptoms of Katigraha in selected patients
2)An improvement of about 30% in range of motion of lower back in patients with Katigraha
3)An improvement of about 30% in quality of life in patients with Katigraha
4)Validation of the safety of ayurveda interventions proposed in Katigraha by assessing ADRs AEs if any
 
Day 0
Day 8
Day 38
 
 
Target Sample Size   Total Sample Size="60"
Sample Size from India="60" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 2/ Phase 3 
Date of First Enrollment (India)   17/09/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

TITLE OF THE STUDY

 

A comparative clinical study to evaluate the efficacy of Dwitiya Baladi Yapana Basti with Trayodashang Guggulu over Eranda Muladi Yapana Basti with Trayodashang Guggulu in the management of Katigraha (Lumbar spondylosis)

 

RESEARCH   QUESTION  Is Dwitiya Baladi Yapana Basti  with Trayodashang guggulu more effective than Eranda Muladi Yapana Basti with Trayodashang Guggulu in the management of Katigraha (Lumbar spondylosis) in patients aged 21 to 50 years?

 

 

NULL HYPOTHESIS  Diwitiya Baladi Yapana Basti with Trayodashang Guggulu is equally effective as Eranda Muladi Yapana Basti with Trayodashang Guggulu.

 

ALTERNATE HYPOTHESIS   Dwitiya Baladi Yapana Basti with Trayodashang Guggulu is more effective than Eranda Muladi Yapana Basti with Trayodashang Guggulu.

OBJECTIVES OF RESEARCH PROJECT

 

 

   PRIMARY OBJECTIVE

        To compare the efficacy of Dwitiya Baladi Yapana Basti  with Trayodashang guggulu over Eranda Muladi Yapana Basti with Trayodashang Guggulu in the management of Katigraha based on Oswestry Disability Index.

 

    SECONDARY OBJECTIVE

       To assess the changes in clinical signs & symptoms of Katigraha i.e. Shoola(pain),Stambh(stiffness),Gaurav(heaviness)

      To assess the changes in range of motion of lower back in patients with Katigraha

       To assess the change in quality of life in patients with Katigraha with Aberdeen LBP Scale 

          To assess the safety of ayurveda interventions proposed in Katigraha

     

A)    INCLUSION CRITERIA

 

1. patients of any gender of  age between 21-50 years.

2. patients having classical clinical signs and symptoms of katigraha (lumbar spondylosis) with   or without  radiological changes (as per KL scale) 

                                             shoola (pain)

                                           stambh (stiffness)

                                          gaurav (heaviness)

3. ODI scale scoring between 5-24.

    ( mild to moderate cases )

4. Aberdeen LBP scale scoring more than 40

5. Controlled Diabetes mellitus, Hypothyroidism, Hypertension

 

ICD 11 code for Lumbar spondylosis - FA8Z

NAMASTE Portal code for Katigraha - SAT-D.1894          

  

      D)EXCLUSION CRITERIA:

 

1.    Patients having any other spinal morbidity like- spinal tumor any  other deformities of lumber spine.

2.      Recent lumbar surgery(Less Than 3yr) or implanted instruments or prostheses.

3.      Chronic inflammatory, metabolic or infective pathologies, i.e. Ankylosing spondylitis,  Rheumatoid  arthritis, Psoriatic arthritis, Gouty arthritis, Pott’s spine,  malignancy &/or metastasis in bones.

4.      Patients using NSAIDs & or corticosteroids on regular basis.

5.      Anorectal conditions like Haemorrhoids, Ano-rectal fistulae, Anal fissure, Anal mass etc. those may interfere with Basti chikitsa.

6.      Pregnant or lactating women.

7.      Any other systemic illnesses like IHD, Epilepsy, COPD etc.

8.      Katigraha due to other causes like malignant diseases of the pelvis.

 ASSESMENT CRITERIA

 

   1) SUBJECTIVE CRITERIA:

        A)Clinical sign and symptoms of Katigraha (Lumabr spondylosis)- Before  treatment and  After treatment:

       Shoola (pain)

      Stambha (stiffness)

        Gaurav (Heaviness)

 

a)      SHOOLA (Pain) By Visual analogue scale.

VAS Scale mentioned in annexure

 

GRADE 0 No pain

GRADE 1 Mild, pain occasionally (1-3 score)

GRADE More than mild but tolerable (4-6 score)

GRADE 3 Severe pain continuous (7-10 score)

 

b)     STAMBH (Stiffness):                

            GRADE0  Absent

GRADE 1: Mild, occasionally GRADE 2: Moderate, for 30-1 hr daily GRADE 3: Severe, persistent

 

c)      GAURAV (Heaviness): GRADE 0: Absent

GRADE 1: Mild, occasionally for 10-30 min

GRADE 2: Moderate for 30-1 hr

GRADE 3: Severe persistence More Than 1 hr

               

                   B) OSWESTRY  DISABILITY INDEX

                 (QUESTIONNAIRE FOR    PATIENTS)

                

     C) ABERDEEN LBP SCALE

                   Mentioned in annexure

                  2)  OBJECTIVE CRITERIA:

 

                 A) RANGE OF MOTION: RoM will be measured with the help of Goniometry.

Flexion -Normal flexion is 900

 Extension-Normal extension is 300

 Lateral Flexion (Rt And Lt) -Normal lateral flexion is 300 on each side

 Rotation – Normal rotation is 300 at both sides

 KL –for screening only

 

     SAMPLE SIZE-

 

The calculated sample size is estimated to be around 36 in each group,
assuming 10% drop outs, we shall be enrolling 40 patients in each group.
 
                                                n =   [Zα/2 + Zβ ]2
                                                       12c(1-c)(pn-0.5)2
                                               
             pn = probability that a score from x is larger than a score from y is larger than 1/2
             c = 1/(1+k) where k = allocation ratio
calculated sample size=40 in each group

Due to time and budget constraints the total sample size will be taken as 60 (30 in each group).

GROUPING –

Intervention

GROUP A

Control Group

GROUP B

Trial Group

Abhyantar Chikitsa

Trayodashang Guggulu 500mg BD B/F

Trayodashang Guggulu 500mg BD B/F

Sarvang abhyanga

 

Dhanvantar Tailam,

Dhanvantar Tailam,

 

Sarvang Bashpa swedan

Dashmoola Kwatha.

 

Dashmoola Kwatha.

Anuvasan Basti

Dhanvantar Tailam.

Dhanvantar Tailam.

Niruha Basti (Yog Basti krama)

Eranda Muladi Yapana Basti 660ml

 

Dwitiya Baladi Yapana Basti 660ml

 

 

Basti

Anuvasan

Niruha

Anuvasan

Niruha

Anuvasan

Niruha

Anuvasan

Anuvasan

Day

1st   day

2nd day

 

3rd  day

4th day

5th day

6th day

7th day

8th day

 

       TOTAL DAYS OF INTERVENTION         08 Days

         FOLLOW UP                                                After 30 Days

        TOTAL DAYS OF STUDY                           38 Days



 
Close